Literature DB >> 24133594

Pathogenesis and significance of glomerular C4d deposition in lupus nephritis: activation of classical and lectin pathways.

Min-Kyung Kim1, Young-In Maeng, Sun-Jae Lee, In Hee Lee, Jisuk Bae, Yu-Na Kang, Byung-Tae Park, Kwan-Kyu Park.   

Abstract

Immune complex-mediated complement activation through the classic pathway plays a key role in the pathogenesis of lupus nephritis (LN). C4d deposition in renal tissue reflects the prognosis of systemic lupus erythematosus (SLE). The aim of the current study is to investigate the pathogenesis and clinicopathologic significance of glomerular C4d deposition in LN. We retrospectively analyzed clinical and histopathological data of 20 SLE patients with renal biopsy-proven LN and 10 non-SLE renal biopsy samples as control. LN biopsies showed varying degrees of glomerular C4d staining associated with immune complex deposits, IgG (p = 0.015), C1q (p = 0.032) and C3 (p = 0.049). 7 LN biopsies had all of C4d, C1q and C3 deposits in their glomeruli, indicative of the activation of the classical pathway, whereas 2 LN biopsies had C4d and C3 deposits without accompanying C1q deposits, indicating the activation of the lectin pathway. Glomerular C4d deposition was correlated with the LN subtype (p < 0.001). In particular, a diffusely intense and coarsely granular pattern of C4d deposition in all glomeruli was detected in class V membranous LN. However, glomerular C4d deposition was correlated with neither disease activity of SLE nor histological activity and chronicity of LN. In conclusion, the activation of the lectin pathway as well as the classical pathway seems to play a crucial role in the pathogenesis of LN. Glomerular C4d staining could be helpful for diagnosing class V membranous LN, although glomerular C4d deposition does not reflect SLE disease activity and histological activity and chronicity.

Entities:  

Keywords:  C4d; Lupus nephritis; classical pathway; disease activity; lectin pathway

Mesh:

Substances:

Year:  2013        PMID: 24133594      PMCID: PMC3796238     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  19 in total

1.  Prospective assessment of C4d deposits on circulating cells and renal tissues in lupus nephritis: a pilot study.

Authors:  I Batal; K Liang; S Bastacky; L P Kiss; T McHale; N L Wilson; B Paul; A Lertratanakul; J M Ahearn; S M Manzi; A H Kao
Journal:  Lupus       Date:  2011-09-29       Impact factor: 2.911

Review 2.  The humoral immune response towards HLA class II determinants in renal transplantation.

Authors:  H E Feucht; G Opelz
Journal:  Kidney Int       Date:  1996-11       Impact factor: 10.612

3.  Immunopathological correlation between mesangial C3d-deposition and C3d-fixing circulating immune complexes in lupus nephritis.

Authors:  E Muso; K Sekita; T Doi; T Kuwahara; H Yoshida; T Tamura; C Kawai; Y Hamashima
Journal:  Clin Immunol Immunopathol       Date:  1984-09

4.  Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity.

Authors:  S Manzi; J E Rairie; A B Carpenter; R H Kelly; S P Jagarlapudi; S M Sereika; T A Medsger; R Ramsey-Goldman
Journal:  Arthritis Rheum       Date:  1996-07

Review 5.  Pathogenesis of lupus nephritis: an update.

Authors:  Sydney Tang; Sing Leung Lui; Kar Neng Lai
Journal:  Nephrology (Carlton)       Date:  2005-04       Impact factor: 2.506

6.  Glomerular C4d deposition indicates in situ classic complement pathway activation, but is not a marker for lupus nephritis activity.

Authors:  Se Hoon Kim; Hyeon Joo Jeong
Journal:  Yonsei Med J       Date:  2003-02       Impact factor: 2.759

7.  Immunoperoxidase staining for C4d on paraffin-embedded tissue in cardiac allograft endomyocardial biopsies: comparison to frozen tissue immunofluorescence.

Authors:  Chavit Chantranuwat; Jian-Hua Qiao; Jon Kobashigawa; Longsheng Hong; Peter Shintaku; Michael C Fishbein
Journal:  Appl Immunohistochem Mol Morphol       Date:  2004-06

8.  Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome.

Authors:  H A Austin; L R Muenz; K M Joyce; T T Antonovych; J E Balow
Journal:  Kidney Int       Date:  1984-04       Impact factor: 10.612

Review 9.  New insights into complement: a mediator of injury and marker of disease activity in systemic lupus erythematosus.

Authors:  S Manzi; J M Ahearn; J Salmon
Journal:  Lupus       Date:  2004       Impact factor: 2.911

10.  Prognostic factors in lupus nephritis. Contribution of renal histologic data.

Authors:  H A Austin; L R Muenz; K M Joyce; T A Antonovych; M E Kullick; J H Klippel; J L Decker; J E Balow
Journal:  Am J Med       Date:  1983-09       Impact factor: 4.965

View more
  10 in total

1.  C4d as a Diagnostic Tool in Proliferative GN.

Authors:  Sanjeev Sethi; Samih H Nasr; An S De Vriese; Fernando C Fervenza
Journal:  J Am Soc Nephrol       Date:  2015-05-19       Impact factor: 10.121

Review 2.  Complement regulation and kidney diseases: recent knowledge of the double-edged roles of complement activation in nephrology.

Authors:  Masashi Mizuno; Yasuhiro Suzuki; Yasuhiko Ito
Journal:  Clin Exp Nephrol       Date:  2017-03-24       Impact factor: 2.801

Review 3.  Renal diseases and the role of complement: Linking complement to immune effector pathways and therapeutics.

Authors:  Tilo Freiwald; Behdad Afzali
Journal:  Adv Immunol       Date:  2021-11-19       Impact factor: 3.543

4.  Association of glomerular C4d deposition with various demographic data in IgA nephropathy patients; a preliminary study.

Authors:  Hamid Nasri; Ali Ahmadi; Mahmood Rafieian-Kopaei; Bahman Bashardoust; Parto Nasri; Muhammed Mubarak
Journal:  J Nephropathol       Date:  2015-01-01

5.  C4d in IgA nephropathy: a marker sans boundaries.

Authors:  Muhammed Mubarak
Journal:  J Nephropharmacol       Date:  2016-01-09

6.  Clinical significance of C4d deposition in renal tissues from patients with primary Sjögren's syndrome-a preliminary study.

Authors:  Wenli Xia; Bixia Gao; Lin Duan; Yan Li; Yubing Wen; Limeng Chen; Xuemei Li; Falei Zheng; Mingxi Li
Journal:  BMC Nephrol       Date:  2019-05-28       Impact factor: 2.388

7.  C4d as a Screening Tool and an Independent Predictor of Clinical Outcomes in Lupus Nephritis and IgA Nephropathy.

Authors:  Xiaoqian Yang; Yanhong Yuan; Xinghua Shao; Huihua Pang; Xiajing Che; Liou Cao; Minfang Zhang; Yao Xu; Zhaohui Ni; Chaojun Qi; Qin Wang; Shan Mou
Journal:  Front Med (Lausanne)       Date:  2022-01-31

8.  Role of C4d in the Diagnosis and Prognosis of Native Renal Diseases.

Authors:  Varsha Kumar; Manoj K Bind; Vatsala Misra; Arvind Gupta; Premala A Singh
Journal:  Indian J Nephrol       Date:  2022-03-11

9.  Epidemiology and Pathophysiology of Glomerular C4d Staining in Native Kidney Biopsies.

Authors:  Cinthia B Drachenberg; John C Papadimitriou; Preeti Chandra; Abdolreza Haririan; Susan Mendley; Matthew R Weir; Mario F Rubin
Journal:  Kidney Int Rep       Date:  2019-07-30

Review 10.  Complement and Complement Targeting Therapies in Glomerular Diseases.

Authors:  Sofia Andrighetto; Jeremy Leventhal; Gianluigi Zaza; Paolo Cravedi
Journal:  Int J Mol Sci       Date:  2019-12-16       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.